SMMT Summit Therapeutics PLC ADRs

Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:SUMM.

$1.77  +0.01 (0.28%)
As of 03/27/2023 11:05:12 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  03/04/2015
Outstanding shares:  697,685,365
Average volume:  4,126,255
Market cap:   $1,186,065,121
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMTVQS7

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%